Inventiva SA ADR IVA 深 沪
已收盘 02-06 16:00:00 美东时间
5.88
+0.080
+1.38%
华盛通- 最 高6.10
- 今 开5.71
- 成交量 29.83万股
- 最 低 5.71
- 昨 收 5.80
- 总市值 11.29亿
- 52周最高 7.9825
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 2.52
- 委 比 -9.37%
- 总股本 1.92亿
- 历史最高 19.064
- 量 比 0.68
- 振 幅 6.72%
- 历史最低 1.53
- 每 手 1
- 风险率 1.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inventiva CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat
Inventiva CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat Inventiva SA will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, which takes place on February 11-12, 2026, at the Lotte New York Palace in New York City. CEO Andrew Obenshain is scheduled for a fire
02-05 05:00
美股大行评级 | 希捷科技、德州仪器、HCA控股、通用汽车、波音、UPS等或多家机构上调目标价；布朗保险、康沃系统、Qorvo、联合健康等遭多家机构下调目标价
今日重点评级关注：Piper Sandler：维持Praxis Precision Medicine"超配"评级，目标价从450美元升至1200美元；Tigress Financial：维持Main International ETF"买入"评级，目标价从52美元升至66美元
01-29 11:06
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug
Biotech Inventiva's 50% surge shows investor optimism over liver disease drug Inventiva shares up 50% in January Optimism builds around its MASH drug Big Pharma signal strategic interest A lot riding out Phase 3 outcome Evaluating funding options, CEO tells Reuters By Danilo Masoni MILAN, Jan 28 (Re
01-28 23:36
Barclays Initiates Coverage On Inventiva with Overweight Rating, Announces Price Target of $18
Barclays analyst Eliana Merle initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating and announces Price Target of $18.
01-28 22:40
美股周涨跌榜 | 算力基建再提速！Galaxy Digital 涨超37%，获批电力容量翻番；创新药企IBRX大涨近137%
算力基建再提速！Galaxy Digital 周涨超37%，获批电力容量翻番；创新药企IBRX周涨近137%，在研创新药获批上市>>
01-17 10:31
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Leerink Partners Initiates Coverage On Inventiva with Outperform Rating, Announces Price Target of $12
Leerink Partners analyst Thomas Smith initiates coverage on Inventiva (NASDAQ:IVA) with a Outperform rating and announces Price Target of $12.
01-12 20:37
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of LexinFintech Holdings Ltd – ADR (NASDAQ:LX) rose sharply in pre-marke...
2025-11-24 18:23
Inventiva S.A reports 9M results
Inventiva S.A (IVA): Revenues for the first nine months of 2025 amounted to €4.5 million, compared to none generated for the same period in 2024. Cash and cash equivalents at €97.6 million, and €24.7 ...
2025-11-22 05:05
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
2025-11-19 11:01
